Oscar Health, Inc. (NYSE:OSCR - Get Free Report) hit a new 52-week low on Monday . The company traded as low as $11.28 and last traded at $11.33, with a volume of 922921 shares. The stock had previously closed at $12.03.
Wall Street Analysts Forecast Growth
Separately, Wells Fargo & Company lowered shares of Oscar Health from an "overweight" rating to an "equal weight" rating and reduced their target price for the stock from $20.00 to $16.00 in a research report on Thursday, March 13th. Two analysts have rated the stock with a sell rating, three have given a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $20.21.
Get Our Latest Stock Analysis on OSCR
Oscar Health Stock Up 1.8 %
The firm's 50 day moving average price is $13.56 and its 200-day moving average price is $14.82. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. The company has a market cap of $3.07 billion, a P/E ratio of -612.19 and a beta of 1.75.
Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. As a group, equities research analysts expect that Oscar Health, Inc. will post 0.69 EPS for the current year.
Hedge Funds Weigh In On Oscar Health
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Oppenheimer & Co. Inc. grew its holdings in Oscar Health by 4.6% during the first quarter. Oppenheimer & Co. Inc. now owns 28,362 shares of the company's stock valued at $372,000 after purchasing an additional 1,250 shares during the period. Prosperity Wealth Management Inc. boosted its position in shares of Oscar Health by 10.6% during the first quarter. Prosperity Wealth Management Inc. now owns 87,676 shares of the company's stock worth $1,149,000 after purchasing an additional 8,399 shares in the last quarter. Princeton Global Asset Management LLC acquired a new position in shares of Oscar Health in the 1st quarter valued at $59,000. Fiduciary Alliance LLC bought a new position in Oscar Health during the first quarter worth about $163,000. Finally, Rhumbline Advisers grew its position in shares of Oscar Health by 6.0% in the 1st quarter. Rhumbline Advisers now owns 287,458 shares of the company's stock valued at $3,769,000 after purchasing an additional 16,231 shares during the period. Institutional investors own 75.70% of the company's stock.
Oscar Health Company Profile
(
Get Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Featured Stories
Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.